- Report
- February 2025
- 200 Pages
Global
From €4195EUR$4,490USD£3,549GBP
- Drug Pipelines
- August 2024
- 180 Pages
Global
From €2336EUR$2,500USD£1,976GBP
- Report
- July 2021
- 50 Pages
China
From €2429EUR$2,600USD£2,055GBP
- Report
- August 2019
- 30 Pages
China
From €2055EUR$2,200USD£1,739GBP
- Report
- June 2023
- 113 Pages
Global
From €4157EUR$4,450USD£3,517GBP
- Report
- July 2023
- 243 Pages
Global
From €7007EUR$7,500USD£5,927GBP
- Report
- August 2022
- 30 Pages
Global
From €2569EUR$2,750USD£2,173GBP
- Report
- February 2024
- 156 Pages
Global
From €7427EUR$7,950USD£6,283GBP
- Report
- August 2024
- 80 Pages
Japan
From €3270EUR$3,500USD£2,766GBP
- Report
- October 2023
- 189 Pages
Global
From €4204EUR$4,500USD£3,556GBP
- Report
- January 2023
- 25 Pages
Global
€11444EUR$12,250USD£9,682GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$4,013USD£3,065GBP
Mycophenolate Mofetil (MMF) is a drug used in the treatment of cardiovascular diseases. It is an immunosuppressant, meaning it reduces the body's immune response. MMF is used to prevent organ rejection in patients who have undergone a heart transplant, as well as to treat certain types of heart failure. It is also used to treat autoimmune diseases such as lupus and rheumatoid arthritis. MMF works by blocking the production of certain proteins that are involved in the body's immune response.
MMF is available in both oral and intravenous forms. It is typically prescribed in combination with other drugs, such as corticosteroids and cyclosporine. The drug is generally well-tolerated, but can cause side effects such as nausea, vomiting, and diarrhea.
The MMF market is highly competitive, with several major pharmaceutical companies offering the drug. These include Novartis, Pfizer, Merck, and Sanofi. Other companies, such as Mylan and Teva, also offer generic versions of the drug. Show Less Read more